| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |